Old Web
English
Sign In
Acemap
>
authorDetail
>
Brenda R. Baldwin
Brenda R. Baldwin
Johns Hopkins University School of Medicine
Biology
Receptor tyrosine kinase
Myeloid leukemia
Leukemia
Immunology
4
Papers
688
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
vitro and in vivo A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in
2010
Mark J. Levis
Jeffrey Allebach
Kam Fai Tse
Brenda R. Baldwin
B. Douglas Smith
Show All
Source
Cite
Save
Citations (0)
FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells
2004
Blood
Rui Zheng
Mark J. Levis
Obdulio Piloto
Patrick Brown
Brenda R. Baldwin
Norbert Claude Gorin
Miloslav Beran
Zhenping Zhu
Dale L. Ludwig
Dan J. Hicklin
Larry Witte
Yiwen Li
Donald Small
Show All
Source
Cite
Save
Citations (189)
Human AML cells in NOD/SCID mice: Engraftment potential and gene expression
2002
Leukemia
Rachata Lumkul
Gorin Nc
Matthew T Malehorn
Hoehn Gt
Rui Zheng
Brenda R. Baldwin
Donald Small
Gore S
Smith D
Paul S. Meltzer
Curt I. Civin
Show All
Source
Cite
Save
Citations (58)
A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo
2002
Blood
Mark J. Levis
Jeffrey Allebach
Kam Fai Tse
Rui Zheng
Brenda R. Baldwin
B. Douglas Smith
Susan Jones-Bolin
Bruce Ruggeri
Craig A. Dionne
Donald Small
Show All
Source
Cite
Save
Citations (441)
1